✦ LIBER ✦
The CHOICE trial: adalimumab demonstrates safety, fistula healing, improved quality of life and increased work productivity in patients with Crohn’s disease who failed prior infliximab therapy
✍ Scribed by S. Lichtiger; D. G. Binion; D. C. Wolf; D. H. Present; A. G. Bensimon; E. Wu; A. P. Yu; A. T. Cardoso; J. Chao; P. M. Mulani; K. G. Lomax; J. D. Kent
- Book ID
- 108606088
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 215 KB
- Volume
- 32
- Category
- Article
- ISSN
- 0269-2813
No coin nor oath required. For personal study only.